Regorafenib receives Priority Review in Japan for colorectal cancer

Bayer AG (Xetra:BAYN) said the Japanese Ministry of Health, Labor and Welfare (MHLW) granted Priority

Read the full 152 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE